SI0758235T1 - Polymer coated tablet comprising amoxycillin and clavulanate - Google Patents

Polymer coated tablet comprising amoxycillin and clavulanate

Info

Publication number: SI0758235T1
Authority: SI; Slovenia
Prior art keywords: amoxycillin; clavulanate; coated tablet; polymer coated; polymer
Prior art date: 1994-04-23

Application number

SI9530526T

Other languages

English (en)

Inventor

C P Conley

N P Davidson

Original Assignee

Smithkline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-04-23

Filing date

1995-04-19

Publication date

2001-10-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10754044&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI0758235(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1995-04-19 Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp

2001-10-31 Publication of SI0758235T1 publication Critical patent/SI0758235T1/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2893—Tablet coating processes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

SI9530526T 1994-04-23 1995-04-19 Polymer coated tablet comprising amoxycillin and clavulanate SI0758235T1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB9408117A GB9408117D0 (en)	1994-04-23	1994-04-23	Pharmaceutical formulations
PCT/EP1995/001463 WO1995028927A1 (en)	1994-04-23	1995-04-19	Polymer coated tablet comprising amoxycillin and clavulanate
EP95917937A EP0758235B1 (en)	1994-04-23	1995-04-19	Polymer coated tablet comprising amoxycillin and clavulanate

Publications (1)

Publication Number	Publication Date
SI0758235T1 true SI0758235T1 (en)	2001-10-31

Family

ID=10754044

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI9530526T SI0758235T1 (en)	1994-04-23	1995-04-19	Polymer coated tablet comprising amoxycillin and clavulanate

Country Status (35)

Country	Link
US (1)	US6051255A (sk)
EP (5)	EP0758235B1 (sk)
JP (1)	JP3622975B2 (sk)
CN (1)	CN1134258C (sk)
AP (2)	AP564A (sk)
AT (6)	ATE223706T1 (sk)
AU (1)	AU684949B2 (sk)
BG (1)	BG62842B1 (sk)
BR (1)	BR9507502A (sk)
CA (1)	CA2188496A1 (sk)
CZ (2)	CZ11376U1 (sk)
DE (5)	DE69521799T2 (sk)
DK (4)	DK1093813T3 (sk)
DZ (1)	DZ1876A1 (sk)
ES (4)	ES2152485T3 (sk)
FI (1)	FI964249A0 (sk)
GB (1)	GB9408117D0 (sk)
GR (2)	GR3035031T3 (sk)
HK (5)	HK1021860A1 (sk)
HU (1)	HU228399B1 (sk)
IL (1)	IL113433A (sk)
MA (1)	MA23528A1 (sk)
MY (1)	MY115351A (sk)
NO (1)	NO310703B1 (sk)
NZ (1)	NZ285080A (sk)
OA (1)	OA10377A (sk)
PL (1)	PL316966A1 (sk)
PT (4)	PT1093813E (sk)
RO (1)	RO116997B1 (sk)
RU (1)	RU2152213C1 (sk)
SA (1)	SA95160343B1 (sk)
SI (1)	SI0758235T1 (sk)
SK (1)	SK282594B6 (sk)
WO (1)	WO1995028927A1 (sk)
ZA (1)	ZA953236B (sk)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9407386D0 (en)	1994-04-14	1994-06-08	Smithkline Beecham Plc	Pharmaceutical formulation
GB9408117D0 (en) *	1994-04-23	1994-06-15	Smithkline Beecham Corp	Pharmaceutical formulations
DZ2028A1 (fr) *	1995-05-03	2002-10-23	Smithkline Beecham Plc	Médicaments destinés au traitement d'infections bactériennes en pédiatrie.
US20030109503A1 (en) *	1995-06-06	2003-06-12	Smithkline Beecham P.L.C.	Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
AU711441B2 (en)	1995-09-07	1999-10-14	Smithkline Beecham Plc	Pharmaceutical formulation
AT407701B (de) *	1996-08-12	2001-05-25	Biochemie Gmbh	Zur direkttablettierung geeignete mischung, die als wesentliche komponenten amoxicillin-trihydrat und das kaliumsalz der clavulansäure enthält und verfahren zur herstellung dieser mischung
TWI225402B (en) *	1996-03-13	2004-12-21	Biochemie Gmbh	Auxiliary-free agglomerates
GB9613470D0 (en)	1996-06-27	1996-08-28	Ciba Geigy Ag	Small solid oral dosage form
GB9616536D0 (en)	1996-08-06	1996-09-25	Quadrant Holdings Cambridge	Co-amoxiclav dosage form
GB9617780D0 (en)	1996-08-24	1996-10-02	Smithkline Beecham Plc	Method of treatment
WO1998034598A2 (en) *	1997-02-07	1998-08-13	Gist-Brocades B.V.	Homogeneous granulated formulations for dose sipping technology
US20030124187A1 (en) *	1997-02-14	2003-07-03	Smithkline Beecham Laboratoires Pharmaceutiques,	Pharmaceutical formulations comprising amoxycillin and clavulanate
EP0975342B1 (en) *	1997-02-14	2003-06-25	Laboratoire GlaxoSmithKline S.A.S.	Pharmaceutical formulations comprising amoxocyllin and clavulanate
TR200000529T2 (tr) *	1997-08-29	2000-08-21	Dsm N.V.	İçinde eksipiyan olmayan granüller
EP1032425A1 (en)	1997-10-31	2000-09-06	Monsanto Company	Gellan gum tablet coating
WO2000041478A2 (en)	1999-04-01	2000-07-20	Dsm N.V.	Agglomerates by crystallisation
US6878386B1 (en)	1999-04-13	2005-04-12	Beecham Pharmaceuticals (Pte) Limited	Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US6294199B1 (en) *	1999-04-13	2001-09-25	Beecham Pharmaceuticals (Pte) Limited	Method of treating a bacterial infection comprising administering amoxycillin
US7250176B1 (en)	1999-04-13	2007-07-31	Beecham Pharmaceuticals (Pte) Limited	Method of treating a bacterial infection
HU229097B1 (en) *	1999-04-13	2013-07-29	Beecham Pharm Pte Ltd	Pharmaceutical compositions containing amoxicilline and clavulanic acid potassium salt
US20040038948A1 (en) *	1999-12-07	2004-02-26	Uhrich Kathryn E.	Therapeutic compositions and methods
GB9930578D0 (en) *	1999-12-23	2000-02-16	Smithkline Beecham Plc	Pharmaceutical formulations
US6544555B2 (en)	2000-02-24	2003-04-08	Advancis Pharmaceutical Corp.	Antibiotic product, use and formulation thereof
US6565882B2 (en) *	2000-02-24	2003-05-20	Advancis Pharmaceutical Corp	Antibiotic composition with inhibitor
US6375982B1 (en) *	2000-07-05	2002-04-23	Capricorn Pharma, Inc.	Rapid-melt semi-solid compositions, methods of making same and method of using same
WO2002002081A1 (en) *	2000-07-05	2002-01-10	Capricorn Pharma, Inc.	Rapid-melt semi-solid compositions, methods of making same and methods of using same
US6756057B2 (en) *	2000-10-12	2004-06-29	Beecham Pharmaceuticals (Pte) Limited	Amoxicillin and potassium clavulanate dosage form
WO2002030392A2 (en)	2000-10-12	2002-04-18	Beecham Pharmaceuticals (Pte) Limited	Formulation containing amoxicillin
US6541014B2 (en) *	2000-10-13	2003-04-01	Advancis Pharmaceutical Corp.	Antiviral product, use and formulation thereof
US20020068078A1 (en) *	2000-10-13	2002-06-06	Rudnic Edward M.	Antifungal product, use and formulation thereof
US20020197314A1 (en) *	2001-02-23	2002-12-26	Rudnic Edward M.	Anti-fungal composition
US20030070584A1 (en) *	2001-05-15	2003-04-17	Cynthia Gulian	Dip coating compositions containing cellulose ethers
AU4061702A (en) *	2001-05-15	2003-04-03	Mcneil-Ppc, Inc.	Dip coating compositions containing starch or dextrin
US8309118B2 (en) *	2001-09-28	2012-11-13	Mcneil-Ppc, Inc.	Film forming compositions containing sucralose
WO2003066053A1 (en) *	2002-02-07	2003-08-14	Rutgers, The State University	Antibiotic polymers
GB0203528D0 (en) *	2002-02-14	2002-04-03	Glaxo Group Ltd	Process and composition
RU2329789C2 (ru) *	2002-02-14	2008-07-27	Глэксо Груп Лимитед	ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ N-[(1-nБУТИЛ-4-ПИПЕРИДИНИЛ)МЕТИЛ]-3,4-ДИГИДРО-2Н-[1,3]ОКСАЗИНО [3,2-a]ИНДОЛ-10-КАРБОКСАМИД ИЛИ ЕГО СОЛЬ, И СПОСОБ ЕЕ ПОЛУЧЕНИЯ, ВКЛЮЧАЮЩИЙ СУХУЮ ГРАНУЛЯЦИЮ
US8637512B2 (en)	2002-07-29	2014-01-28	Glaxo Group Limited	Formulations and method of treatment
KR100456833B1 (ko) *	2002-08-01	2004-11-10	주식회사 대웅	아목시실린 및 클라불라네이트를 함유하는 유핵정
US7429619B2 (en) *	2002-08-02	2008-09-30	Mcneil Consumer Healthcare	Polyacrylic film forming compositions
CA2406592C (en) *	2002-10-04	2003-09-30	Duchesnay Inc.	Method of preparing pharmaceutical dosage forms containing multiple active ingredients
US7405210B2 (en)	2003-05-21	2008-07-29	Osi Pharmaceuticals, Inc.	Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase
CA2533292C (en)	2003-07-21	2013-12-31	Advancis Pharmaceutical Corporation	Antibiotic product, use and formulation thereof
WO2005009364A2 (en) *	2003-07-21	2005-02-03	Advancis Pharmaceutical Corporation	Antibiotic product, use and formulation thereof
US8313776B2 (en) *	2003-07-21	2012-11-20	Shionogi Inc.	Antibiotic product, use and formulation thereof
EP1653925A1 (en) *	2003-08-11	2006-05-10	Advancis Pharmaceutical Corporation	Robust pellet
US8062672B2 (en) *	2003-08-12	2011-11-22	Shionogi Inc.	Antibiotic product, use and formulation thereof
WO2005023184A2 (en) *	2003-08-29	2005-03-17	Advancis Pharmaceuticals Corporation	Antibiotic product, use and formulation thereof
DE10341264A1 (de)	2003-09-04	2005-03-24	Grünenthal GmbH	Schmelzformulierte, multipartikuläre orale Darreichungsform
AU2004273830B2 (en) *	2003-09-15	2011-03-24	Shionogi, Inc.	Antibiotic product, use and formulation thereof
EP1701705A4 (en) *	2003-12-24	2007-08-08	Advancis Pharmaceutical Corp	IMPROVED ABSORPTION OF DOSAGE FORMS WITH MODIFIED RELEASE
ES2353309T3 (es)	2004-03-08	2011-03-01	Prosidion Ltd.	Hidrazidas del ácido pirrolopiridin-2-carboxílico como inhibidores de glucógeno fosforilasa.
CA2572292A1 (en) *	2004-07-02	2006-02-09	Advancis Pharmaceutical Corporation	Tablet for pulsed delivery
KR100638315B1 (ko) *	2004-07-23	2006-10-25	주식회사 대웅제약	다중 필름 코팅된 코어층을 갖는 클라불라네이트 및아목시실린-함유 유핵정
KR101318032B1 (ko)	2005-05-20	2013-10-14	다이이찌 산쿄 가부시키가이샤	필름 코팅 제제
KR100780553B1 (ko) *	2005-08-18	2007-11-29	한올제약주식회사	메트포르민 서방정 및 그의 제조방법
US8778924B2 (en) *	2006-12-04	2014-07-15	Shionogi Inc.	Modified release amoxicillin products
US8357394B2 (en)	2005-12-08	2013-01-22	Shionogi Inc.	Compositions and methods for improved efficacy of penicillin-type antibiotics
US8299052B2 (en)	2006-05-05	2012-10-30	Shionogi Inc.	Pharmaceutical compositions and methods for improved bacterial eradication
CL2008003230A1 (es) *	2007-11-01	2009-11-27	Sanofi Aventis Healthcare Pty Ltd	Composicion de recubrimiento de tableta que comprende polimero celulosico, plastificante, edulcorante y composicion de sabor en polvo la que comprende saborizante asociado con portador solido; fluido de recubrimiento de tableta que comprende dicha composicion; tableta farmaceutica; proceso de preparacion de dicha tableta.
WO2011032929A1 (en) *	2009-09-18	2011-03-24	Sanofi-Aventis	(z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluormethylphenyl)-amide tablet formulations with improved stability
TR200909787A2 (tr)	2009-12-25	2011-07-21	Bi̇lgi̇ç Mahmut	Üçüncü kuşak bir sefalosporin ve klavulanik asit içeren farmasötik formülasyonlar.
TR201000686A1 (tr)	2010-01-29	2011-08-22	B�Lg�� Mahmut	Bakteriyel enfeksiyonların tedavisinde suda çözünebilir sefdinir ve klavulanik asit formülasyonları.@
TR201000688A2 (tr)	2010-01-29	2011-08-22	B�Lg�� Mahmut	Aktif madde olarak sefaklor ve klavulanik asit içeren efervesan formülasyonlar.
TR201000687A1 (tr)	2010-01-29	2011-08-22	Bi̇lgi̇ç Mahmut	Aktif madde olarak sefiksim ve klavulanik asit içeren efervesan formülasyonlar
JP6041591B2 (ja) *	2011-09-13	2016-12-14	大日本住友製薬株式会社	イルベサルタンとアムロジピンまたはその塩を含有する安定化された医薬組成物
US9387250B2 (en)	2013-03-15	2016-07-12	Rutgers, The State University Of New Jersey	Therapeutic compositions for bone repair

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1241844A (en)	1968-08-23	1971-08-04	Beecham Group Ltd	Penicillins
GB1508977A (en)	1974-04-20	1978-04-26	Beecham Group Ltd	Beta-lactam antibiotic from streptomyces clavuligerus
US4098897A (en) *	1975-04-14	1978-07-04	Beecham Group Limited	Anti bacterial agents
JO984B1 (en) *	1977-10-11	1979-12-01	بيتشام غروب ليمتد	A dry pharmaceutical compound with a suitable dosage unit for oral administration
NZ198241A (en) *	1980-09-27	1983-12-16	Beecham Group Ltd	Tablet containing amoxycillin and potassium clavulanate
DE3266580D1 (en) *	1981-12-02	1985-10-31	Beecham Group Plc	Pharmaceutical formulation comprising beta-lactam antibiotics
GB9408117D0 (en) *	1994-04-23	1994-06-15	Smithkline Beecham Corp	Pharmaceutical formulations
HU229097B1 (en) *	1999-04-13	2013-07-29	Beecham Pharm Pte Ltd	Pharmaceutical compositions containing amoxicilline and clavulanic acid potassium salt
WO2002030392A2 (en) *	2000-10-12	2002-04-18	Beecham Pharmaceuticals (Pte) Limited	Formulation containing amoxicillin

1994
- 1994-04-23 GB GB9408117A patent/GB9408117D0/en active Pending
1995
- 1995-04-13 AP APAP/P/1995/000733A patent/AP564A/en active
- 1995-04-19 SI SI9530526T patent/SI0758235T1/xx unknown
- 1995-04-19 JP JP52733495A patent/JP3622975B2/ja not_active Expired - Lifetime
- 1995-04-19 DK DK00204182T patent/DK1093813T3/da active
- 1995-04-19 CN CNB951934023A patent/CN1134258C/zh not_active Expired - Lifetime
- 1995-04-19 EP EP95917937A patent/EP0758235B1/en not_active Expired - Lifetime
- 1995-04-19 ES ES96202848T patent/ES2152485T3/es not_active Expired - Lifetime
- 1995-04-19 WO PCT/EP1995/001463 patent/WO1995028927A1/en active IP Right Grant
- 1995-04-19 DE DE69521799T patent/DE69521799T2/de not_active Expired - Lifetime
- 1995-04-19 RU RU96122474/14A patent/RU2152213C1/ru active
- 1995-04-19 SK SK1354-96A patent/SK282594B6/sk not_active IP Right Cessation
- 1995-04-19 PT PT00204182T patent/PT1093813E/pt unknown
- 1995-04-19 PT PT99200891T patent/PT978276E/pt unknown
- 1995-04-19 EP EP02076874A patent/EP1243267A3/en not_active Withdrawn
- 1995-04-19 CA CA002188496A patent/CA2188496A1/en not_active Abandoned
- 1995-04-19 AT AT99200891T patent/ATE223706T1/de active
- 1995-04-19 PT PT95917937T patent/PT758235E/pt unknown
- 1995-04-19 ES ES99200891T patent/ES2180251T3/es not_active Expired - Lifetime
- 1995-04-19 DE DE69528608T patent/DE69528608T2/de not_active Revoked
- 1995-04-19 PT PT96202848T patent/PT761218E/pt unknown
- 1995-04-19 DK DK95917937T patent/DK0758235T3/da active
- 1995-04-19 AT AT96202848T patent/ATE196845T1/de not_active IP Right Cessation
- 1995-04-19 NZ NZ285080A patent/NZ285080A/en not_active IP Right Cessation
- 1995-04-19 DE DE69519093T patent/DE69519093T2/de not_active Expired - Fee Related
- 1995-04-19 DE DE69528204T patent/DE69528204T2/de not_active Expired - Lifetime
- 1995-04-19 ES ES00204182T patent/ES2182754T3/es not_active Expired - Lifetime
- 1995-04-19 DE DE29522153U patent/DE29522153U1/de not_active Expired - Lifetime
- 1995-04-19 AU AU24068/95A patent/AU684949B2/en not_active Expired
- 1995-04-19 EP EP00204182A patent/EP1093813B1/en not_active Revoked
- 1995-04-19 BR BR9507502A patent/BR9507502A/pt not_active IP Right Cessation
- 1995-04-19 DK DK96202848T patent/DK0761218T3/da active
- 1995-04-19 RO RO96-02030A patent/RO116997B1/ro unknown
- 1995-04-19 EP EP99200891A patent/EP0978276B1/en not_active Expired - Lifetime
- 1995-04-19 CZ CZ200011418U patent/CZ11376U1/cs not_active IP Right Cessation
- 1995-04-19 ES ES95917937T patent/ES2161288T3/es not_active Expired - Lifetime
- 1995-04-19 PL PL95316966A patent/PL316966A1/xx unknown
- 1995-04-19 CZ CZ19963090A patent/CZ294168B6/cs not_active IP Right Cessation
- 1995-04-19 AT AT00204182T patent/ATE226074T1/de not_active IP Right Cessation
- 1995-04-19 HU HU9602922A patent/HU228399B1/hu unknown
- 1995-04-19 EP EP96202848A patent/EP0761218B1/en not_active Revoked
- 1995-04-19 AP APAP/P/1996/000868A patent/AP9600868A0/en unknown
- 1995-04-19 DK DK99200891T patent/DK0978276T3/da active
- 1995-04-19 US US08/727,581 patent/US6051255A/en not_active Expired - Lifetime
- 1995-04-19 AT AT95917937T patent/ATE203161T1/de active
- 1995-04-20 MY MYPI95001037A patent/MY115351A/en unknown
- 1995-04-20 IL IL11343395A patent/IL113433A/xx unknown
- 1995-04-21 MA MA23858A patent/MA23528A1/fr unknown
- 1995-04-21 ZA ZA953236A patent/ZA953236B/xx unknown
- 1995-04-22 DZ DZ950044A patent/DZ1876A1/fr active
- 1995-10-25 SA SA95160343A patent/SA95160343B1/ar unknown
1996
- 1996-10-22 FI FI964249A patent/FI964249A0/fi not_active Application Discontinuation
- 1996-10-22 NO NO19964488A patent/NO310703B1/no not_active IP Right Cessation
- 1996-10-23 BG BG100933A patent/BG62842B1/bg unknown
- 1996-10-23 OA OA60908A patent/OA10377A/en unknown
1998
- 1998-09-21 HK HK99105804A patent/HK1021860A1/xx not_active IP Right Cessation
- 1998-09-21 HK HK01107178A patent/HK1036404A1/xx not_active IP Right Cessation
- 1998-09-21 HK HK03101681.9A patent/HK1050992A1/zh unknown
- 1998-09-21 HK HK00104976A patent/HK1027024A1/xx not_active IP Right Cessation
- 1998-09-21 HK HK98110787A patent/HK1009936A1/xx not_active IP Right Cessation
2000
- 2000-07-18 AT AT0052400U patent/AT5349U1/de not_active IP Right Cessation
- 2000-12-12 GR GR20000402718T patent/GR3035031T3/el not_active IP Right Cessation
2001
- 2001-04-11 AT AT0028501U patent/AT5350U1/de not_active IP Right Cessation
- 2001-10-09 GR GR20010401708T patent/GR3036844T3/el unknown

Also Published As

Publication number	Publication date
EP1093813A3 (en)	2001-05-30
AP9600868A0 (en)	1996-10-31
GB9408117D0 (en)	1994-06-15
NO310703B1 (no)	2001-08-20
ATE196845T1 (de)	2000-10-15
HK1036404A1 (en)	2002-01-04
DE69521799T2 (de)	2002-06-13
IL113433A0 (en)	1995-07-31
HK1027024A1 (en)	2001-01-05
SK282594B6 (sk)	2002-10-08
RU2152213C1 (ru)	2000-07-10
DE69528608T2 (de)	2003-06-26
EP1243267A3 (en)	2002-10-30
CZ11376U1 (cs)	2001-07-12
ES2180251T3 (es)	2003-02-01
DZ1876A1 (fr)	2002-02-17
NO964488D0 (no)	1996-10-22
EP0978276B1 (en)	2002-09-11
AP564A (en)	1996-11-21
AP9500733A0 (en)	1995-04-30
EP0978276A2 (en)	2000-02-09
EP0758235B1 (en)	2001-07-18
DK1093813T3 (da)	2003-02-17
NZ285080A (en)	1998-05-27
US6051255A (en)	2000-04-18
EP0761218B1 (en)	2000-10-11
JPH09512027A (ja)	1997-12-02
SA95160343B1 (ar)	2005-05-04
FI964249L (fi)	1996-10-22
PL316966A1 (en)	1997-03-03
OA10377A (en)	2001-11-21
HK1009936A1 (en)	1999-06-11
ES2161288T3 (es)	2001-12-01
EP1093813B1 (en)	2002-10-16
DK0978276T3 (da)	2003-01-20
HU9602922D0 (en)	1996-12-30
AU2406895A (en)	1995-11-16
NO964488L (no)	1996-12-17
PT978276E (pt)	2003-01-31
MY115351A (en)	2003-05-31
DE69519093T2 (de)	2001-07-19
ES2152485T3 (es)	2001-02-01
PT761218E (pt)	2001-03-30
DE69528204T2 (de)	2003-08-07
SK135496A3 (en)	1997-05-07
AU684949B2 (en)	1998-01-08
MA23528A1 (fr)	1995-12-31
DE69521799D1 (de)	2001-08-23
HK1021860A1 (en)	2000-07-07
DK0761218T3 (da)	2000-12-18
EP0761218A1 (en)	1997-03-12
EP1093813A2 (en)	2001-04-25
EP0758235A1 (en)	1997-02-19
ATE203161T1 (de)	2001-08-15
GR3036844T3 (en)	2002-01-31
ATE223706T1 (de)	2002-09-15
EP1243267A2 (en)	2002-09-25
FI964249A0 (fi)	1996-10-22
CA2188496A1 (en)	1995-11-02
DK0758235T3 (da)	2001-10-29
CZ294168B6 (cs)	2004-10-13
ZA953236B (en)	1995-12-27
CN1149829A (zh)	1997-05-14
DE69519093D1 (de)	2000-11-16
EP0978276A3 (en)	2000-04-12
IL113433A (en)	2003-06-24
PT1093813E (pt)	2003-02-28
AT5349U1 (de)	2002-06-25
ATE226074T1 (de)	2002-11-15
RO116997B1 (ro)	2001-09-28
BR9507502A (pt)	1997-09-02
DE29522153U1 (de)	2000-04-06
DE69528204D1 (de)	2002-10-17
BG62842B1 (bg)	2000-09-29
PT758235E (pt)	2001-10-31
JP3622975B2 (ja)	2005-02-23
CZ309096A3 (en)	1997-04-16
HK1050992A1 (zh)	2003-07-18
BG100933A (en)	1997-07-31
HU228399B1 (en)	2013-03-28
ES2182754T3 (es)	2003-03-16
HUT76335A (en)	1997-08-28
CN1134258C (zh)	2004-01-14
AT5350U1 (de)	2002-06-25
DE69528608D1 (de)	2002-11-21
GR3035031T3 (en)	2001-03-30
WO1995028927A1 (en)	1995-11-02

Publication	Publication Date	Title
GR3036844T3 (en)	2002-01-31	Polymer coated tablet comprising amoxycillin and clavulanate
GB2298422B (en)	1997-01-29	Compounds and their use
ZA966494B (en)	1997-02-03	New drugs and their use
AU2505795A (en)	1996-02-01	1-arylpyrimidine derivatives and pharmaceutical use thereof
HUP9901092A3 (en)	2001-11-28	Benzimidazole compounds and their pharmaceutical use
AU7237394A (en)	1995-02-20	Morphinan derivative and medicinal use
AU5772196A (en)	1996-11-29	3,4-disubstituted-phenylsulphonamides and their therapeutic use
HUP9901437A3 (en)	2000-03-28	Pharmaceutical formulation, containing amoxycillin and clavulanate
AU4009795A (en)	1996-05-15	Heterocyclic compounds and their use
AU5772296A (en)	1996-11-29	3,4-disubstituted-phenylsulphonamides and their therapeutic use
AP9701122A0 (en)	1997-10-31	Composition comprising amoxycillin and clavulanic acid
AU1081897A (en)	1997-06-19	Heterocyclic compounds and their use
AU3634595A (en)	1996-03-29	Bis-oxazolidines and their use
AU2512495A (en)	1995-12-05	Therapeutic phenoxyalkylazoles and phenoxyalkylazines
AU7529796A (en)	1997-06-05	S-nitroso-hemoglobin and therapeutic uses thereof
GB9514816D0 (en)	1995-09-20	Substances and their medical use
HUP9602872A3 (en)	1999-03-01	Penem derivatives and antimicrobial agent containing the same
AU7551896A (en)	1997-05-29	1-azabicycloheptane derivatives and their pharmaceutical use
AU6366096A (en)	1997-02-10	Solid polymeric products and their use
AU1292995A (en)	1995-06-13	Bis-oxazolidine compounds and their use
AU7078094A (en)	1995-02-06	Allatostatins and their use
AU1141497A (en)	1997-06-19	Heterocyclic compounds and their use
AU5405296A (en)	1996-11-18	Iso-alpha-acid formulation and its use
AU6470996A (en)	1997-02-18	4a-aryldecahydroisoquinoline compounds and medicinal uses thereof
AU5930996A (en)	1996-12-18	Contrast medium and its use